Beam Therapeutics (BEAM) Non-cash Items (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Non-cash Items data on file, last reported at $7.6 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $7.6 million, down 93.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.6 million (down 93.09% YoY), and the FY2025 annual result was $7.4 million, up 25.13% from the prior year.
• Non-cash Items climbed to $7.6 million in Q1 2026 per BEAM's latest filing, from $7.4 million in the prior quarter.
• Over five years, Non-cash Items peaked at $152.5 million in Q2 2023 and troughed at $2.6 million in Q1 2022.
• A 5-year average of $53.8 million and a median of $37.2 million in 2024 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items plunged 96.81% in 2022, then surged 4974.06% in 2023.
• A 5-year view of Non-cash Items shows it stood at $111.0 million in 2022, then tumbled by 53.46% to $51.7 million in 2023, then declined by 28.02% to $37.2 million in 2024, then slumped by 80.16% to $7.4 million in 2025, then gained by 2.65% to $7.6 million in 2026.
• Business Quant data shows BEAM's Non-cash Items at $7.6 million in Q1 2026, $7.4 million in Q4 2025, and $84.2 million in Q3 2025.